The CGM that lasts a year
Eversense (eversensediabetes.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 64th percentile of 7761 Healthcare brands.
Eversense is a continuous glucose monitoring (CGM) system for people with diabetes, marketed under the Eversense 365 name. It is distinguished by a sensor designed to last a full year, reducing the frequency of sensor changes compared to other CGM products. The brand targets both individuals managing diabetes and healthcare professionals who prescribe and oversee CGM systems, positioning itself around long-term durability, reliability, and simplicity in glucose monitoring.
| Brand Name | Eversense |
|---|---|
| Domain | eversensediabetes.com |
| Industry | Healthcare, Technology |
| Main Competitors | Dexcom (92/100), Abbott FreeStyle Libre, Medtronic Guardian |
Moz Domain Authority 41/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Actively manage your diabetes with confidence & simplicity with the Eversense® CGM sensor. Learn more." (Meta description: 15 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: ASP.NET, Cloudflare.
Social footprint: verified profiles on Facebook, X (Twitter), Instagram, YouTube; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Eversense?", Claude could identify the brand as of September 2026. Eversense is the brand name for an implantable continuous glucose monitoring (CGM) system developed by Senseonics, marketed in partnership with Ascensia Diabetes Care. Its key differentiator is a sensor inserted under the skin that lasts up to 180 days (compared to the 10-14 day Best known for The long-term implantable CGM sensor (up to 6 months) as an alternative to disposable, adhesive-patch CGMs.
When asked "Best brands similar to Eversense?", Claude would recommend Eversense as of September 2026. It's a legitimate and distinctive player in the CGM market, so it's worth mentioning alongside Dexcom and FreeStyle Libre for users wanting a longer-lasting, implantable option.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Eversense has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 19, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Eversense official site
Eversense scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Eversense official site
Eversense can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Eversense official site
Eversense offers a continuous glucose monitoring (CGM) system, with its primary product being Eversense 365-a sensor implanted under the skin that provides continuous glucose readings for up to one year. The system is designed for both individuals managing diabetes and healthcare professionals who prescribe and monitor CGM use for their patients.
Sources: Eversense official site
Eversense is used by people living with diabetes who require continuous glucose monitoring to manage their condition, as well as by healthcare professionals who prescribe and oversee CGM systems for their patients.
Sources: Eversense official site
Eversense is a continuous glucose monitoring (CGM) system designed for people with diabetes. Its flagship product, Eversense 365, features a sensor that can remain implanted for up to a full year, distinguishing it from other CGM systems that require more frequent sensor replacement. It is marketed on eversensediabetes.com and is described in its knowledge-graph context as being associated with clinical trials, indicating a basis in clinical research.
Sources: Eversense official site
Eversense provides continuous glucose monitoring technology that helps people with diabetes track their glucose levels over time. Its core offering, the Eversense 365 sensor, is designed to last a full year, reducing the need for frequent sensor changes. The system is intended to give users and healthcare professionals reliable, long-term data for managing diabetes with greater confidence and simplicity.
Sources: Eversense official site
Eversense is known for offering a continuous glucose monitoring sensor, Eversense 365, that lasts a full year-longer than other CGM systems on the market, which typically require sensor changes every one to two weeks. This long-lasting design is the brand's key differentiator in the diabetes management technology space.
Sources: Eversense official site
Eversense scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Eversense has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (49/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 41/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Eversense from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Eversense: Europe PMC (79/100), ERWEKA (79/100), Evex (79/100), Extenze (79/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.